Literature DB >> 10955954

HLA and beta-myosin heavy chain do not influence susceptibility to Chagas disease cardiomyopathy.

K C Faé1, S A Drigo, E Cunha-Neto, B Ianni, C Mady, J Kalil, A C Goldberg.   

Abstract

An inflammatory dilated cardiomyopathy occurs in 30% of Chagas' disease patients, chronically infected by Trypanosoma cruzi, while the remaining infected individuals are asymptomatic. Studies have indicated a role for genetic factors in the susceptibility to Chagas' disease cardiomyopathy. In an attempt to identify the genetic factors influencing the development and outcome of Chagas' cardiomyopathy, we compared the frequencies of alleles from two candidate gene loci, class II HLA and a microsatellite marker for the human cardiac beta-myosin heavy chain gene in different clinical groups. Patients were grouped as asymptomatic or with severe or mild cardiomyopathy. The results indicate that the HLA and myosin microsatellite allele profiles in all cardiomyopathy and in asymptomatic groups are similar. In conclusion, these results establish that polymorphism of HLA-DR and -DQ molecules, as well as beta-cardiac myosin, do not influence the susceptibility to different clinical forms of Chagas' disease or the progression to severe Chagas' cardiomyopathy. On the other hand, male sex was identified as a risk factor for progression to the more severe forms of cardiomyopathy (relative risk = 8.75).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10955954     DOI: 10.1016/s1286-4579(00)00501-3

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  11 in total

Review 1.  Chronic Chagas' heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine.

Authors:  Silvia Gilka Muñoz-Saravia; Annekathrin Haberland; Gerd Wallukat; Ingolf Schimke
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

2.  Protective human leucocyte antigen haplotype, HLA-DRB1*01-B*14, against chronic Chagas disease in Bolivia.

Authors:  Florencia del Puerto; Juan Eiki Nishizawa; Mihoko Kikuchi; Yelin Roca; Cinthia Avilas; Alberto Gianella; Javier Lora; Freddy Udalrico Gutierrez Velarde; Sachio Miura; Norihiro Komiya; Koji Maemura; Kenji Hirayama
Journal:  PLoS Negl Trop Dis       Date:  2012-03-20

3.  Evidence for T Cell Help in the IgG Response against Tandemly Repetitive Trypanosoma cruzi B13 Protein in Chronic Chagas Disease Patients.

Authors:  Marcia Duranti; Ludmila Camargo; Gabriel Victora; Barbara Ianni; Paula Buck; Charles Mady; Jorge Kalil; Bianca Zingales; Edecio Cunha-Neto
Journal:  J Parasitol Res       Date:  2012-02-19

4.  Genes from Chagas susceptibility loci that are differentially expressed in T. cruzi-resistant mice are candidates accounting for impaired immunity.

Authors:  Sebastian E B Graefe; Thomas Streichert; Birgit S Budde; Peter Nürnberg; Christiane Steeg; Bertram Müller-Myhsok; Bernhard Fleischer
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

5.  Genetic susceptibility to Chagas disease cardiomyopathy: involvement of several genes of the innate immunity and chemokine-dependent migration pathways.

Authors:  Amanda Farage Frade; Cristina Wide Pissetti; Barbara Maria Ianni; Bruno Saba; Hui Tzu Lin-Wang; Luciana Gabriel Nogueira; Ariana de Melo Borges; Paula Buck; Fabrício Dias; Monique Baron; Ludmila Rodrigues Pinto Ferreira; Andre Schmidt; José Antonio Marin-Neto; Mario Hirata; Marcelo Sampaio; Abílio Fragata; Alexandre Costa Pereira; Eduardo Donadi; Jorge Kalil; Virmondes Rodrigues; Edecio Cunha-Neto; Christophe Chevillard
Journal:  BMC Infect Dis       Date:  2013-12-12       Impact factor: 3.090

6.  Genetic Polymorphisms of IL17 and Chagas Disease in the South and Southeast of Brazil.

Authors:  Pâmela Guimarães Reis; Christiane Maria Ayo; Luiz Carlos de Mattos; Cinara de Cássia Brandão de Mattos; Karina Mayumi Sakita; Amarilis Giaretta de Moraes; Larissa Pires Muller; Julimary Suematsu Aquino; Luciana Conci Macedo; Priscila Saamara Mazini; Ana Maria Sell; Divina Seila de Oliveira Marques; Reinaldo Bulgarelli Bestetti; Jeane Eliete Laguila Visentainer
Journal:  J Immunol Res       Date:  2017-04-02       Impact factor: 4.818

Review 7.  Genetic susceptibility to Chagas disease: an overview about the infection and about the association between disease and the immune response genes.

Authors:  Christiane Maria Ayo; Márcia Machado de Oliveira Dalalio; Jeane Eliete Laguila Visentainer; Pâmela Guimarães Reis; Emília Ângela Sippert; Luciana Ribeiro Jarduli; Hugo Vicentin Alves; Ana Maria Sell
Journal:  Biomed Res Int       Date:  2013-08-28       Impact factor: 3.411

8.  The MHC gene region of murine hosts influences the differential tissue tropism of infecting Trypanosoma cruzi strains.

Authors:  Jorge M Freitas; Luciana O Andrade; Simone F Pires; Ricardo Lima; Egler Chiari; Ricardo R Santos; Milena Soares; Carlos R Machado; Gloria R Franco; Sergio D J Pena; Andrea M Macedo
Journal:  PLoS One       Date:  2009-04-01       Impact factor: 3.240

9.  Polymorphism in the alpha cardiac muscle actin 1 gene is associated to susceptibility to chronic inflammatory cardiomyopathy.

Authors:  Amanda Farage Frade; Priscila Camilo Teixeira; Barbara Maria Ianni; Cristina Wide Pissetti; Bruno Saba; Lin Hui Tzu Wang; Andréia Kuramoto; Luciana Gabriel Nogueira; Paula Buck; Fabrício Dias; Helene Giniaux; Agnes Llored; Sthefanny Alves; Andre Schmidt; Eduardo Donadi; José Antonio Marin-Neto; Mario Hirata; Marcelo Sampaio; Abílio Fragata; Edimar Alcides Bocchi; Antonio Noedir Stolf; Alfredo Inacio Fiorelli; Ronaldo Honorato Barros Santos; Virmondes Rodrigues; Alexandre Costa Pereira; Jorge Kalil; Edecio Cunha-Neto; Christophe Chevillard
Journal:  PLoS One       Date:  2013-12-19       Impact factor: 3.240

Review 10.  Chagas disease cardiomyopathy: immunopathology and genetics.

Authors:  Edecio Cunha-Neto; Christophe Chevillard
Journal:  Mediators Inflamm       Date:  2014-08-19       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.